0

    531762

    UNJHAFOR

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    UNJHA FORMULATIONS LTD. Share Price Today

    Investment Returns

    Over 1 Month 50.99% Over 3 Months 26.49% Over 6 Months 18.19% Over 1 Year 0.07%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    UNJHA FORMULATIONS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 11.90
    • P/E Ratio (TTM) 16.88
    • Beta 0.35
    • Book Value / share 8.57
    • Return on equity 8.77%
    • EPS (TTM) 1.57
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.74
    info icon alternate text

    UNJHA FORMULATIONS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 3.28
    Operating Expense 3.82
    Net Profit -0.74
    Net Profit Margin (%) -22.56
    Earnings Per Share (EPS) -1.66
    EBITDA -0.45
    Effective Tax Rate (%) -51.02
    Particulars DEC 2025 (Values in Cr)
    Revenue 4.41
    Operating Expense 4.20
    Net Profit 0.24
    Net Profit Margin (%) 5.44
    Earnings Per Share (EPS) 0.53
    EBITDA 0.27
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 4.29
    Operating Expense 3.53
    Net Profit 0.82
    Net Profit Margin (%) 19.11
    Earnings Per Share (EPS) 1.83
    EBITDA 0.85
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 3.61
    Operating Expense 3.24
    Net Profit 0.39
    Net Profit Margin (%) 10.80
    Earnings Per Share (EPS) 0.90
    EBITDA 0.42
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.37
    Operating Expense 2.73
    Net Profit -0.41
    Net Profit Margin (%) -17.29
    Earnings Per Share (EPS) -0.91
    EBITDA -0.26
    Effective Tax Rate (%) -41.37
    Particulars MAR 2026 (Values in Cr)
    Revenue 15.59
    Operating Expense 14.79
    Net Profit 0.70
    Net Profit Margin (%) 4.49
    Earnings Per Share (EPS) 1.57
    EBITDA 1.10
    Effective Tax Rate (%) 26.31
    Particulars MAR 2025 (Values in Cr)
    Revenue 13.86
    Operating Expense 13.45
    Net Profit 0.41
    Net Profit Margin (%) 2.95
    Earnings Per Share (EPS) 0.91
    EBITDA 0.63
    Effective Tax Rate (%) 23.07
    Particulars MAR 2024 (Values in Cr)
    Revenue 18.50
    Operating Expense 18.06
    Net Profit 0.28
    Net Profit Margin (%) 1.51
    Earnings Per Share (EPS) 0.62
    EBITDA 0.59
    Effective Tax Rate (%) 37.77
    Particulars MAR 2023 (Values in Cr)
    Revenue 13.15
    Operating Expense 12.86
    Net Profit 0.28
    Net Profit Margin (%) 2.12
    Earnings Per Share (EPS) 0.63
    EBITDA 0.47
    Effective Tax Rate (%) 15.15
    Particulars MAR 2022 (Values in Cr)
    Revenue 14.16
    Operating Expense 14.05
    Net Profit 0.25
    Net Profit Margin (%) 1.76
    Earnings Per Share (EPS) 0.56
    EBITDA 0.51
    Effective Tax Rate (%) 16.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.01
    ROE % 8.77
    ROCE % 11.55
    Total Debt to Total Equity 0.00
    EBITDA Margin 4.55
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 6.10
    ROE % 6.00
    ROCE % 10.71
    Total Debt to Total Equity 0.00
    EBITDA Margin 3.14
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 5.48
    ROE % 6.00
    ROCE % 8.35
    Total Debt to Total Equity 0.00
    EBITDA Margin 3.57
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4.84
    ROE % 5.35
    ROCE % 9.20
    Total Debt to Total Equity 0.00
    EBITDA Margin 3.60
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 4.28
    ROE % 2.14
    ROCE % 5.78
    Total Debt to Total Equity 0.00
    EBITDA Margin 3.51
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.64
    Total Assets 4.55
    Total Liabilities 4.55
    Total Equity 3.13
    Share Outstanding 0
    Price to Book Ratio 3.11
    Return on Assets (%) 8.94
    Return on Capital (%) 12.98
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.87
    Total Assets 4.93
    Total Liabilities 4.93
    Total Equity 2.73
    Share Outstanding 0
    Price to Book Ratio 3.10
    Return on Assets (%) 5.63
    Return on Capital (%) 10.18
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 3.40
    Total Liabilities 3.40
    Total Equity 2.45
    Share Outstanding 0
    Price to Book Ratio 2.28
    Return on Assets (%) 8.28
    Return on Capital (%) 11.52
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.42
    Total Assets 3.45
    Total Liabilities 3.45
    Total Equity 2.17
    Share Outstanding 0
    Price to Book Ratio 1.94
    Return on Assets (%) 7.30
    Return on Capital (%) 11.63
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.17
    Total Assets 3.52
    Total Liabilities 3.52
    Total Equity 1.91
    Share Outstanding 0
    Price to Book Ratio 1.99
    Return on Assets (%) 2.93
    Return on Capital (%) 5.4
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.52
    Cash from Operations 0.09
    Cash from Investing -0.17
    Cash from Financing 0.00
    Net change in Cash -0.23
    Free Cash Flow 0.28
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.45
    Cash from Operations 1.07
    Cash from Investing -0.10
    Cash from Financing -0.05
    Net change in Cash 0.86
    Free Cash Flow 1.18
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.32
    Cash from Operations -0.21
    Cash from Investing -0.09
    Cash from Financing -0.05
    Net change in Cash -0.41
    Free Cash Flow -0.10
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.25
    Cash from Operations 0.40
    Cash from Investing -0.02
    Cash from Financing 0.00
    Net change in Cash 0.25
    Free Cash Flow 0.43
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.10
    Cash from Operations -0.53
    Cash from Investing -0.06
    Cash from Financing 0.00
    Net change in Cash -0.76
    Free Cash Flow -0.46
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    UNJHA FORMULATIONS LTD. shareholding pattern

    Holding
    63.07%
    36.92%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    UNJHA FORMULATIONS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    26.50 -1.77 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 25.80
    • 26 Days 22.00
    • 10 Days 24.30
    • 50 Days 21.20
    • 12 Days 23.80
    • 100 Days 21.20
    • 20 Days 22.50
    • 200 Days 22.10
    27.28 PIVOT
    First Support 26.68 First Resistance 27.58 Second Support 26.38 Second Resistance 28.18 Third Support 25.78 Third Resistance 28.48
    RSI 73.55 ADX 25.56 MACD 1.81 Williams % R -13.51 Commodity Channel Index (CCI) 125.79
    Date 2026-07-17 Week 14838.00 Same Day 4413.00 Month 6095.00
    1 Year 0.36 3 Year 0.30
    Over 1 Month
    50.99% down
    Over 1 Year
    0.07% down
    Over 3 Months
    26.49% down
    Over 3 Years
    26.79% down
    Over 6 Months
    18.19% down
    Over 5 Years
    22.23% down

    UNJHA FORMULATIONS LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Unjha Formulations Ltd?

    Answer Field

    Unjha Formulations Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 26.50 as on Jul 17 2026 03:15 PM.

    What is the Market Cap of Unjha Formulations Ltd Share?

    Answer Field

    The market cap of Unjha Formulations Ltd for NSE ₹ 0.00 & for BSE ₹ 11.90 as on Jul 17 2026 03:15 PM.

    What is the 52 Week High and Low of Unjha Formulations Ltd?

    Answer Field

    The 52 Week High and Low of Unjha Formulations Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 28.85 and ₹ 17.52.

    What is 1 year return for Unjha Formulations Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.07%.

    What is the P/E Ratio of Unjha Formulations Ltd Share?

    Answer Field

    As on Jul 17 2026 03:15 PM the price-to-earnings (PE) ratio for Unjha Formulations Ltd share is 16.88.

    What is the PB ratio of Unjha Formulations Ltd Share?

    Answer Field

    As on Jul 17 2026 03:15 PM, the price-to-book (PB) ratio for Unjha Formulations Ltd share is 8.57.

    How to Buy Unjha Formulations Ltd Share?

    Answer Field

    You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Unjha Formulations Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Unjha Formulations Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Unjha Formulations Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |